Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Metformin can help diagnose and treat high testosterone levels in women, often due to insulin resistance rather than a tumor.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Most patients improved with oral contraceptives, but some needed additional treatment.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.